[go: up one dir, main page]

AU2003242428A1 - Drugs improved in tissue selectivity - Google Patents

Drugs improved in tissue selectivity

Info

Publication number
AU2003242428A1
AU2003242428A1 AU2003242428A AU2003242428A AU2003242428A1 AU 2003242428 A1 AU2003242428 A1 AU 2003242428A1 AU 2003242428 A AU2003242428 A AU 2003242428A AU 2003242428 A AU2003242428 A AU 2003242428A AU 2003242428 A1 AU2003242428 A1 AU 2003242428A1
Authority
AU
Australia
Prior art keywords
tissue selectivity
drugs improved
drugs
improved
selectivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242428A
Inventor
Yoshiyuki Fujimura
Yasuhiro Kuwahara
Yukiko Nishimura
Kouichi Sekiya
Ken Ubasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2003242428A1 publication Critical patent/AU2003242428A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003242428A 2002-05-24 2003-05-23 Drugs improved in tissue selectivity Abandoned AU2003242428A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002-151507 2002-05-24
JP2002151507 2002-05-24
JP2002-151506 2002-05-24
JP2002151506 2002-05-24
PCT/JP2003/006463 WO2003099294A1 (en) 2002-05-24 2003-05-23 Drugs improved in tissue selectivity

Publications (1)

Publication Number Publication Date
AU2003242428A1 true AU2003242428A1 (en) 2003-12-12

Family

ID=29585976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242428A Abandoned AU2003242428A1 (en) 2002-05-24 2003-05-23 Drugs improved in tissue selectivity

Country Status (3)

Country Link
AU (1) AU2003242428A1 (en)
TW (1) TW200402299A (en)
WO (1) WO2003099294A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066074A2 (en) 2004-12-16 2006-06-22 The Regents Of The University Of California Lung-targeted drugs
WO2013095684A1 (en) 2011-12-22 2013-06-27 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
US8835630B1 (en) 2013-03-15 2014-09-16 The Regents Of The University Of California, A California Corporation Acyclic nucleoside phosphonate diesters
BR112017005111B1 (en) 2014-09-15 2023-02-14 The Regents Of The University Of California ACYCLIC NUCLEOTIDE ANALOG COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS, AND USES OF THE COMPOSITION IN THE TREATMENT OF A PAPILLOMAVIRUS INFECTION
EP3350191B9 (en) 2015-09-15 2021-12-22 The Regents of the University of California Nucleotide analogs
AU2023310177A1 (en) 2022-07-21 2025-03-06 Antiva Biosciences, Inc. Compositions and dosage forms for treatment of hpv infection and hpv-induced neoplasia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020093824A (en) * 2000-02-29 2002-12-16 미쯔비시 웰 파마 가부시키가이샤 Phosphonate nucleotide compound

Also Published As

Publication number Publication date
TW200402299A (en) 2004-02-16
WO2003099294A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
EP2289512B8 (en) Pharmaceutical foam
AU2003217740A1 (en) Non-invasive stationary system
AU2003249176A1 (en) Multilayered tissue products
AU2003281505A1 (en) Chair
AU2003229738A1 (en) Medicament dispenser
AU2003276447A1 (en) Inhalers
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003248153A1 (en) Honey-based skin care preparation
AU2003255372A1 (en) Medical device
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003264541A1 (en) Medical material
AU2003264406A1 (en) Drug or cosmetic
AU2003242428A1 (en) Drugs improved in tissue selectivity
AU2003213146A1 (en) Activated protein c formulations
AU2003256112A1 (en) Patient bed
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003229499A1 (en) Disposable barbecue
AU2003241937A1 (en) Examination chair
AU2003283533A1 (en) Medicated comestibles
AU2003268985A1 (en) Cannula
AU2003231937A1 (en) Therapeutic methods
AU2003229752A1 (en) Human rhomboid-related protein
AU2003230338A1 (en) Chair
HK1072601A (en) Pharmaceutical combination
AU2003902516A0 (en) Therapeutic compositions - II

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase